Related Experiment Video
Updated: Sep 19, 2025

Supramaximal Intensity Hypoxic Exercise and Vascular Function Assessment in Mice
Published on: March 15, 2019
β-Adrenergic receptors mediate sex differences in vasodilation but not sympathetic-mediated vasoconstriction during
Dain W Jacob1, Brian Shariffi1, Braden J Bond1
1Department of Nutrition and Exercise Physiology, University of Missouri, Columbia, Missouri, United States.
Abstract:
β-Adrenergic receptors (ARs) mediate a portion of hypoxic vasodilation and blunt sympathetic vasoconstriction at rest. Vascular β-AR sensitivity may be greater in females relative to males; however, their sex-specific role during hypoxia has yet to be examined. We hypothesized β-AR blockade would blunt hypoxic vasodilation and augment sympathetic vasoconstriction during hypoxia, with effects greater in females relative to males. Ten female (26 ± 8 yr, 23 ± 3 kg/m2) and 13 male (28 ± 7 yr, 25 ± 2 kg/m2) adults completed two study visits randomized and blinded to oral placebo or propranolol (β-AR blockade; 1 mg/kg) (NCT05256069). Forearm blood flow (FBF, venous occlusion plethysmography) and blood pressure (BP, finger photoplethysmography) were assessed for 10-min normoxic rest, followed by 5 min of steady-state hypoxia (∼80% [Formula: see text]). Sympathetic activation was achieved via a cold pressor test (CPT) conducted during normoxia and steady-state hypoxia. FBF was normalized for mean BP (forearm vascular conductance, FVC). Absolute (Δ) and relative (%) changes in FVC in response to hypoxia and CPT were calculated. β-AR blockade significantly reduced hypoxic vasodilation in females but not in males (interaction of hypoxia and sex: ΔFVC P = 0.029, %FVC P = 0.030). Sympathetic vasoconstriction was attenuated during hypoxia in females compared with males (main effect of sex: ΔFVC P = 0.005, %FVC P = 0.015), but there was no effect of β-AR blockade in either sex (main effect of drug: ΔFVC P = 0.406; %FVC P = 0.238; interaction of drug and sex: ΔFVC P = 0.619, %FVC P = 0.390). β-Adrenergic receptors mediate hypoxic dilation in females but not in males and do not restrain sympathetic-mediated vasoconstriction during hypoxia in either sex.NEW & NOTEWORTHY β-Adrenergic receptors contribute to hypoxic vasodilation, attenuate sympathetic vasoconstriction at rest, and are more sensitive in females versus males. We hypothesized β-adrenergic receptor blockade would blunt hypoxic vasodilation and augment the sympathetic vasoconstriction during hypoxia, with effects greater in females relative to males. Present data demonstrate β-adrenergic receptors contribute to hypoxic vasodilation in females but do not restrain sympathetic-mediated vasoconstriction during hypoxia in either sex.
More Related Videos
Related Concept Videos
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenergic Receptors (Adrenoceptors): Classification
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
Sympathetic Signaling
Sympathetic preganglionic fibers release the neurotransmitter acetylcholine (ACh) onto the ganglionic neurons in the...
Adrenergic Agonists: Direct-Acting Agents
These agents can be classified...
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...

